Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Linkage of Multiple Sclerosis and Guillain-Barre Syndrome: A Population-Based Survey in Isfahan, Iran Publisher



Etemadifar M1 ; Roomizadeh P2, 3 ; Abtahi SH2, 3, 4 ; Sajjadi S2, 3 ; Abedini A2, 3 ; Golabbakhsh A2, 3 ; Fereidanesfahani M2, 3 ; Akbari M2, 3
Authors

Source: Autoimmune Diseases Published:2012


Abstract

Background. Multiple Sclerosis (MS) and Guillain Barre Syndrome (GBS) are autoimmune demyelinating disorders of Central and Peripheral Nervous system, respectively. The coexistence of these two syndromes in an individual's life span is rare. Objectives. To inspect throughout Isfahan MS society (IMSS) records for MS cases who had history of documented GBS whether before the onset of MS or after it. Methods. This retrospective survey was carried out by analyzing the clinical records of 3,522 MS patients who were registered with IMSS, from April 2003 to July 2010. Eligible cases were requested to attend to IMSS for final clinical/paraclinical examinations. Results. Among 3,522 (2,716 women and 806 men) MS subjects, we could identify seven patients (six females and one male) with documented diagnosis of GBS. Six patients (five women and one man) had developed MS within 6.5±7.0 (range: 1-16) years after being diagnosed with GBS and one (a woman) had developed GBS three years after the diagnosis of MS. Conclusion. It seems that the development of MS in individuals with history of GBS is more than a simple incidental event. © 2012 Masoud Etemadifar et al.
1. Mannose-Binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders, Iranian Journal of Allergy, Asthma and Immunology (2016)
2. Clinical Features and Outcome of Guillain-Barre Syndrome in Children, Iranian Journal of Child Neurology (2018)
3. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
Experts (# of related papers)
Other Related Docs
11. Lateonset Multiple Sclerosis in Isfahan, Iran, Archives of Iranian Medicine (2012)
14. Facial Involvement in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
15. Serum Level of Interleukin 36 in Patients With Multiple Sclerosis, Journal of Immunoassay and Immunochemistry (2018)